Wells Fargo & Company Tyra Biosciences, Inc. Transaction History
Wells Fargo & Company
- $407 Billion
- Q2 2024
A detailed history of Wells Fargo & Company transactions in Tyra Biosciences, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 6,506 shares of TYRA stock, worth $138,187. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,506
Previous 4,725
37.69%
Holding current value
$138,187
Previous $77,000
35.06%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding TYRA
# of Institutions
77Shares Held
43.4MCall Options Held
0Put Options Held
0-
Ra Capital Management, L.P. Boston, MA10.4MShares$221 Million2.51% of portfolio
-
Boxer Capital, LLC San Diego, CA6.45MShares$137 Million5.73% of portfolio
-
Bvf Inc San Francisco, CA4.66MShares$99 Million2.28% of portfolio
-
Canaan Partners Xi LLC Menlo Park, CA4.41MShares$93.7 Million85.38% of portfolio
-
Nextech Invest Ag4.06MShares$86.1 Million12.24% of portfolio
About Tyra Biosciences, Inc.
- Ticker TYRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,973,600
- Market Cap $892M
- Description
- Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The comp...